Last updated on July 2019

Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis


Brief description of study

Study estimating the clinical difference between 300 mg and 150 mg of secukinumab following dose escalation to 300 mg in patients with ankylosing spondylitis

Clinical Study Identifier: NCT03350815

Find a site near you

Start Over

Novartis Investigative Site

Jonesboro, AR United States
  Connect »

Novartis Investigative Site

Fullerton, CA United States
  Connect »

Novartis Investigative Site

Huntington Beach, CA United States
  Connect »

Novartis Investigative Site

Loma Linda, CA United States
  Connect »

Novartis Investigative Site

Palm Desert, CA United States
  Connect »

Novartis Investigative Site

Danbury, CT United States
  Connect »

Novartis Investigative Site

Aventura, FL United States
  Connect »

Novartis Investigative Site

Boca Raton, FL United States
  Connect »

Novartis Investigative Site

Brandon, FL United States
  Connect »

Novartis Investigative Site

Gainesville, FL United States
  Connect »

Novartis Investigative Site

Orlando, FL United States
  Connect »

Novartis Investigative Site

Plantation, FL United States
  Connect »

Novartis Investigative Site

Saint Petersburg, FL United States
  Connect »

Novartis Investigative Site

Tamarac, FL United States
  Connect »

Novartis Investigative Site

Springfield, IL United States
  Connect »

Novartis Investigative Site

Vernon Hills, IL United States
  Connect »

Novartis Investigative Site

Evansville, IN United States
  Connect »

Novartis Investigative Site

Hagerstown, MD United States
  Connect »

Novartis Investigative Site

Wheaton, MD United States
  Connect »

Novartis Investigative Site

Ann Arbor, MI United States
  Connect »

Novartis Investigative Site

Saint Clair Shores, MI United States
  Connect »

Novartis Investigative Site

Midland Park, NJ United States
  Connect »

Novartis Investigative Site

Voorhees, NJ United States
  Connect »

Novartis Investigative Site

Albuquerque, NM United States
  Connect »

Novartis Investigative Site

Santa Fe, NM United States
  Connect »

Novartis Investigative Site

Brooklyn, NY United States
  Connect »

Novartis Investigative Site

New York, NY United States
  Connect »

Novartis Investigative Site

Orchard Park, NY United States
  Connect »

Novartis Investigative Site

Potsdam, NY United States
  Connect »

Novartis Investigative Site

Cincinnati, OH United States
  Connect »

Novartis Investigative Site

Middleburg Heights, OH United States
  Connect »

Novartis Investigative Site

Oklahoma City, OK United States
  Connect »

Novartis Investigative Site

Corvallis, OR United States
  Connect »

Novartis Investigative Site

Portland, OR United States
  Connect »

Novartis Investigative Site

Duncansville, PA United States
  Connect »

Novartis Investigative Site

Wexford, PA United States
  Connect »

Novartis Investigative Site

Charleston, SC United States
  Connect »

Novartis Investigative Site

Columbia, SC United States
  Connect »

Novartis Investigative Site

Jackson, TN United States
  Connect »

Novartis Investigative Site

Memphis, TN United States
  Connect »

Novartis Investigative Site

Beaumont, TX United States
  Connect »

Novartis Investigative Site

Colleyville, TX United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

Mesquite, TX United States
  Connect »

Novartis Investigative Site

Salt Lake City, UT United States
  Connect »

Novartis Investigative Site

Seattle, WA United States
  Connect »

Novartis Investigative Site

Spokane, WA United States
  Connect »

Novartis Investigative Site

Manitowoc, WI United States
  Connect »

Novartis Investigative Site

Onalaska, WI United States
  Connect »